Langenau Erik E, Sandella Jeanne M
National Board of Osteopathic Medical Examiners (NBOME) National Center for Clinical Skills Testing in Conshohocken, Pennsylvania, USA.
J Am Osteopath Assoc. 2011 Jul;111(7):432-6.
In 2007, The National Board of Osteopathic Medical Examiners (NBOME) instituted a policy to address the accuracy and integrity of postencounter written documentation recorded during the Comprehensive Osteopathic Medical Licensing Examination Level 2-Performance Evaluation (COMLEX-USA Level 2-PE). This policy was instituted not only to protect the integrity of the examination, but also to highlight that overdocumentation of clinical findings not obtained during patient encounters may jeopardize patient safety.
To investigate overall and domain pass/fail patterns of candidates who misrepresented clinical findings with regard to past and subsequent performance on COMLEX-USA Level 2-PE. Specifically, to investigate what percentage of candidates failed because of misrepresentation on first attempts and how they performed on subsequent administrations, as well as the previous performance patterns of candidates who failed because of misrepresentation on examination retakes.
Historical records from NBOME's COMLEX-USA Level 2-PE database (testing cycles 2007-2008, 2008-2009, and 2009-2010) were used to analyze overall and domain pass/fail patterns of candidates who failed at least once because of misrepresentation of clinical findings.
Of the 24 candidates who failed because of misrepresentation of postencounter (SOAP) notes, 20 candidates (83%) were first-time examinees. Four candidates (17%) were repeating the examination, 2 of whom were making a third attempt to pass. Among these 20 candidates who failed because of misrepresentation of clinical findings on their first attempt, 19 passed on their next attempt. At the time of study analysis, all but 2 candidates eventually passed the examination in subsequent attempts.
Among candidates found to have misrepresented clinical findings on postencounter written documentation on COMLEX-USA Level 2-PE, no pattern existed between their past or subsequent performance with regard to overall or domain pass/fail results. The vast majority of these candidates passed the examination on subsequent administrations, and none failed twice because of misrepresentation. Consequences of misrepresentation of clinical findings on COMLEX-USA Level 2-PE are severe and may serve to both raise awareness and prevent these types of errors in the future.
2007年,美国骨病医学考试委员会(NBOME)制定了一项政策,以解决在综合骨病医学执照考试二级——实践评估(COMLEX - USA二级-PE)期间记录的会诊后书面文件的准确性和完整性问题。制定这项政策不仅是为了保护考试的公正性,也是为了强调在患者会诊期间未获取的临床发现过度记录可能会危及患者安全。
调查在COMLEX - USA二级-PE中就过去和后续表现而言虚报临床发现的考生的总体及各领域的通过/未通过模式。具体而言,调查因虚报而首次考试未通过的考生比例,以及他们在后续考试中的表现,还有因在重考时虚报而未通过的考生之前的表现模式。
使用NBOME的COMLEX - USA二级-PE数据库(2007 - 2008年、2008 - 2009年和2009 - 2010年考试周期)中的历史记录,分析因临床发现虚报而至少有一次未通过的考生的总体及各领域通过/未通过模式。
在因会诊后(SOAP)记录虚报而未通过的24名考生中,20名考生(83%)是首次参加考试者。4名考生(17%)在重考,其中2人是第三次尝试通过考试。在这20名因首次考试时虚报临床发现而未通过的考生中,19人在下一次考试时通过了。在研究分析时,除2名考生外,所有考生最终在后续考试中通过了考试。
在COMLEX - USA二级-PE的会诊后书面文件中被发现虚报临床发现的考生中,他们过去或后续在总体或各领域通过/未通过结果方面不存在模式。这些考生中的绝大多数在后续考试中通过了考试,且没有人因虚报而两次未通过。在COMLEX - USA二级-PE中虚报临床发现的后果很严重,可能有助于提高认识并防止未来出现这类错误。